Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.

 

The Medtronic HeartWare Ventricular Assist Devices (HVAD) has a Class I FDA recall.
Feature | Ventricular Assist Devices (VAD) | June 04, 2018

June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its...

Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018

May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...

FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018

April 2, 2018 — Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval...

Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018

March 13, 2018 — At two years of follow-up, severely ill patients with advanced...

Abiomed Receives Expanded Impella Approval for Cardiomyopathy With Cardiogenic Shock
News | Hemodynamic Support Devices | February 15, 2018

February 15, 2018 — Abiomed Inc. announced that it received an expanded U.S. Food and Drug Administration (FDA) Pre-...

Abiomed Impella percutaneous ventricular assist device (pVAD) heart pump gains FDA PMA for high risk PCI.
Feature | Hemodynamic Support Devices | February 14, 2018

February 14, 2018 — Abiomed Inc. announced it received an expanded U.S. Food and Drug Administration (FDA) pre-...

Technavio Market Study Shows Donor Shortage and Improved Survival Rate
News | Hemodynamic Support Devices | January 25, 2018

January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support...

CorInnova Awarded 2017 InnoSTARS Prize for EpicHeart Soft Robotic Heart Assist Device
News | Artificial Heart | December 11, 2017

December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life...

Surgery Could Reduce Frailty in Adults With Heart Failure
News | Heart Failure | November 17, 2017

November 17, 2017 — Common practice, and recently published research, shows that the risk of complications with...

CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device
News | Artificial Heart | October 27, 2017

October 27, 2017 — CorInnova Inc. announced it has received notice of allowance of a seminal patent to protect its...

Detroit Cardiogenic Shock Initiative Goes National at TCT 2017
News | Hemodynamic Support Devices | October 26, 2017

October 26, 2017 — Medical professionals representing hospital systems from across the United States are expected to...

Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017

October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System...

Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD) | September 28, 2017

September 28, 2017 — Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA...

Overlay Init